Tetra Bio-Pharma CBD Topical Preparation Gets Orphan Drug Designation in Europe – MarketWatch

/
/

By Adriano Marchese Tetra Bio-Pharma Inc. said Wednesday that its cannabidiol-based topical preparation has been classified as an orphan medicinal …

  • Facebook
  • Twitter
  • Google+
  • Linkedin
  • Pinterest
This div height required for enabling the sticky sidebar